EUVIMEDEUVIMED entdecken
Crossref

Statistical Analysis Plan for the Chinese Herbal Medicine in Acute Intracerebral Hemorrhage Trial

Qiang Li, Craig S Anderson, Rustam Al-Shahi Salman, Graeme J Hankey, Laurent Billot, Yang Zhao, Guanghai Tang, Jianwen Guo, Lili Song, CHAIN Investigators

Cerebrovascular Diseases · 2024

DOI: 10.1159/000540444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases, 2024. Verfasst von Qiang Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia, qli@georgeinstitute.org. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Drugs, Chinese Herbal. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The traditional Chinese medicine herbal compound FYTF-919 (Zhong Feng Xing Nao prescription) may improve outcome from acute intracerebral hemorrhage by reducing brain edema, hematoma absorption, and enhancement of the immune system. We outline the statistical analysis plan (SAP) for the Chinese Herbal medicine in Acute INtracerebral hemorrhage (CHAIN) study. CHAIN is a multicenter, prospective, randomized, double-blind, placebo-controlled trial being undertaken at 20–30 hospitals in China. After the completion of eligibility checks, patients are randomly allocated to FYTF-919 (100 mL per day, oral) or matching placebo over 28 days. A sample size of 1,504 patients is estimated to provide 90% power (α 0.05) for a 0.06 absolute improvement in the primary outcome of utility-weighted modified Rankin scale scores at 90 days, analyzed by general linear regression.

Methods

The SAP was developed by the study statistician, principal investigators, international experts, and the study project manager. The plan provides details for analyzing baseline characteristics, patient management, and outcomes. It includes provisions for covariate adjustments, subgroup analysis, the handling missing data, and in the conduct of sensitivity analyses.

Discussion

A predefined SAP was established for CHAIN, facilitating transparent and verifiable analysis. The CHAIN SAP was prospectively developed with a focus on maintaining high-quality standards of internal validity to minimize potential analysis biases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageDrugs, Chinese HerbalHumansDouble-Blind MethodTreatment OutcomeProspective StudiesRandomized Controlled Trials as TopicChinaMulticenter Studies as TopicTime FactorsData Interpretation, StatisticalAcute DiseaseResearch Design

Stichwörter der Autor:innen

Chinese herbal medicineClinical trialIntracerebral hemorrhageStatistical analysis planStroke

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia, qli@georgeinstitute.org.
  • The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.
  • The George Institute for Global Health China, Beijing, China.
  • Centre for Clinical Brain Sciences and Edinburgh Clinical Trials Unit, The University of Edinburgh, Edinburgh, UK.
  • Centre for Neuromuscular and Neurological Disorders, Medical School, The University of Western Australia and Perron Institute for Neurological and Translational Science, Perth, Washington, Australia.

Zitieren

APA

Li, Q., Anderson, C. S., Al-Shahi Salman, R., Hankey, G. J., Billot, L., Zhao, Y., Tang, G., Guo, J., Song, L., & CHAIN Investigators (2024). Statistical Analysis Plan for the Chinese Herbal Medicine in Acute Intracerebral Hemorrhage Trial. Cerebrovascular Diseases. https://doi.org/10.1159/000540444

Vancouver

Li Q, Anderson CS, Al-Shahi Salman R, Hankey GJ, Billot L, Zhao Y, et al. Statistical Analysis Plan for the Chinese Herbal Medicine in Acute Intracerebral Hemorrhage Trial. Cerebrovascular Diseases. 2024. doi:10.1159/000540444

BibTeX
@article{Li2024,
  author = {Li, Qiang and Anderson, Craig S and Al-Shahi Salman, Rustam and Hankey, Graeme J and Billot, Laurent and Zhao, Yang and Tang, Guanghai and Guo, Jianwen and Song, Lili and CHAIN Investigators, CHAIN Investigators},
  title = {Statistical Analysis Plan for the Chinese Herbal Medicine in Acute Intracerebral Hemorrhage Trial},
  journal = {Cerebrovascular Diseases},
  year = {2024},
  doi = {10.1159/000540444}
}
Kostenlos starten →